These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8521411

  • 21. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA, Wright JA.
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [Abstract] [Full Text] [Related]

  • 22. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
    Cosgaya JM, Aranda A.
    Oncogene; 1996 Jun 20; 12(12):2651-60. PubMed ID: 8700524
    [Abstract] [Full Text] [Related]

  • 23. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
    Mi Y, Borger DR, Fernandes PR, Pirisi L, Creek KE.
    Virology; 2000 May 10; 270(2):408-16. PubMed ID: 10793000
    [Abstract] [Full Text] [Related]

  • 24. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones.
    Raymond VW, Lee DC, Grisham JW, Earp HS.
    Cancer Res; 1989 Jul 01; 49(13):3608-12. PubMed ID: 2786455
    [Abstract] [Full Text] [Related]

  • 25. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 01; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 26. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
    Jakowlew SB, Mathias A, Chung P, Moody TW.
    Cell Growth Differ; 1995 Apr 01; 6(4):465-76. PubMed ID: 7794814
    [Abstract] [Full Text] [Related]

  • 27. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
    Kim ES, Kim MS, Moon A.
    Cytokine; 2005 Jan 21; 29(2):84-91. PubMed ID: 15598443
    [Abstract] [Full Text] [Related]

  • 28. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

  • 29. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, Clark R, McCormick F, Dickson RB, Lippman ME.
    Cancer Res; 1989 Nov 15; 49(22):6269-74. PubMed ID: 2553252
    [Abstract] [Full Text] [Related]

  • 30. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A.
    Biochem J; 2002 Dec 15; 368(Pt 3):683-93. PubMed ID: 12223100
    [Abstract] [Full Text] [Related]

  • 31. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
    Sheng H, Shao J, O'Mahony CA, Lamps L, Albo D, Isakson PC, Berger DH, DuBois RN, Beauchamp RD.
    Oncogene; 1999 Jan 28; 18(4):855-67. PubMed ID: 10023661
    [Abstract] [Full Text] [Related]

  • 32. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6.
    McGee DW, Beagley KW, Aicher WK, McGhee JR.
    J Immunol; 1993 Jul 15; 151(2):970-8. PubMed ID: 8335922
    [Abstract] [Full Text] [Related]

  • 35. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
    Franzén P, Ichijo H, Miyazono K.
    Exp Cell Res; 1993 Jul 15; 207(1):1-7. PubMed ID: 7686495
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
    Braun L, Dürst M, Mikumo R, Gruppuso P.
    Cancer Res; 1990 Nov 15; 50(22):7324-32. PubMed ID: 2171761
    [Abstract] [Full Text] [Related]

  • 38. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM.
    Cancer Res; 1999 Oct 01; 59(19):4834-42. PubMed ID: 10519393
    [Abstract] [Full Text] [Related]

  • 39. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW, Raymond VW, Tsao MS, Lee DC, Earp HS, Grisham JW.
    Cancer Res; 1991 Oct 01; 51(19):5238-44. PubMed ID: 1717143
    [Abstract] [Full Text] [Related]

  • 40. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.
    Huggett AC, Hampton LL, Ford CP, Wirth PJ, Thorgeirsson SS.
    Cancer Res; 1990 Dec 01; 50(23):7468-75. PubMed ID: 2174726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.